About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

2.775 +0.055 (+2.02%)

Streaming Delayed Price Updated: 11:13 AM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

22 23 Next >

Iovance Biotherapeutics: Q4 Earnings Insights ↗

February 28, 2024

Via Benzinga

Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

February 28, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics's Earnings: A Preview ↗

February 27, 2024

Via Benzinga

3 Stocks Flashing Recent Insider Buying Signals ↗

February 27, 2024

One way to spot an opportunity is by paying attention to insider buying stocks. After all, it’s the insiders that know their company.

Via InvestorPlace

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 ↗

February 26, 2024

Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential.

Via InvestorPlace

1 Soaring Growth Stock That Could Rise Another 53%, According to Wall Street ↗

February 26, 2024

A successful launch of its first approved therapy could push shares of this innovative new cancer drug developer through the roof.

Via The Motley Fool

Is Iovance a Buy After Its First Regulatory Win? ↗

February 25, 2024

Iovance Biotherapeutics has found a new way to treat cancer.

Via The Motley Fool

Unpacking the Latest Options Trading Trends in Iovance Biotherapeutics ↗

February 23, 2024

Via Benzinga

Iovance Biotherapeutics Unusual Options Activity For February 22 ↗

February 22, 2024

Via Benzinga

This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst ↗

February 23, 2024

It has good news in hand and plenty of room to grow.

Via The Motley Fool

2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value ↗

February 23, 2024

These two businesses have viable paths to making investors richer -- possibly soon.

Via The Motley Fool

Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024

February 22, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗

February 22, 2024

MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.

Via Talk Markets

Why Iovance Biotherapeutics Stock Is Skyrocketing Today ↗

February 20, 2024

Iovance is no longer a clinical-stage biotech.

Via The Motley Fool

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 21, 2024

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 21, 2024

Via Benzinga

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volume Charts in Wednesday Trading

February 21, 2024

Via Investor Brand Network

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday ↗

February 21, 2024

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Via Benzinga

Why Is Iovance Therapeutics (IOVA) Stock Up 35% Today? ↗

February 20, 2024

With Iovance Therapeutics gaining FDA approval for its novel skin cancer therapeutic, IOVA stock is proving the bears wrong.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 20, 2024

Via Benzinga

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) Near Top of Volume Charts in Tuesday Trading

February 20, 2024

Via Investor Brand Network

Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday ↗

February 20, 2024

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.

Via Benzinga

Topics Stocks

What's Going On With Iovance Biotherapeutics Stock? ↗

February 20, 2024

Iovance Biotherapeutics announced Tuesday that the U.S. Food and Drug Administration (FDA) approved the company to begin analytical testing and manufacturing of AMTAGVI at its Philadelphia site....

Via Benzinga

Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

February 20, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

February 20, 2024

Shares of Discover Financial Services (NYSE: DFS) shares rose sharply in today’s pre-market trading.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 20, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 20, 2024

Pre-market stock movers are a hot topic on Tuesday morning as we start the day with a breakdown of all the latest stock market news!

Via InvestorPlace

Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock

February 20, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 19, 2024

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

All News about Iovance Biotherapeutics, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us